The opening of the UK’s first safer drugs consumption room will be a “significant step forward” in efforts to tackle Scotland ...

A new era, where AI is at the centre of the drug discovery process is emerging, says Charlotte Deane, a professor of ...

A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor.

Chip designer AMD said Wednesday that it will invest $20 million in Absci, the Vancouver company that aims to use artificial intelligence to develop new drug therapies.

The U.S. Food and Drug Administration (FDA) recently announced final guidance for firms in the medical device and product industry ...

Absci shares are rising after announcing a strategic collaboration with Advanced Micro Devices Inc. The partnership will ...

Stoke Therapeutics (STOK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Andrew Fein ...

Insilico Medicine ('Insilico'), a clinical-stage generative artificial intelligence (AI)-driven drug discovery and development company, today announces positive results from two Phase I studies in ...

Pfizer is expanding its collaboration with the start-up PostEra, which applies artificial intelligence to medicinal chemistry ...

On December 5, 2024, the U.S. Food and Drug Administration (FDA or Agency) issued a draft guidance entitled Expedited Program for ...

Nitrogen atoms and nitrogen-containing chemical structures, known as heterocycles, play a crucial role in medicinal chemistry ...

By combining diverse datasets and powerful analytical and modeling tools, drug developers are finding more potential ...